NCT02909075|Completed
A Study to Assess Thymic Function Using PET/CT and MRI
An Initial Study of FDG-PET/CT and MRI to Assess Thymic Function
Loading search results
An Initial Study of FDG-PET/CT and MRI to Assess Thymic Function
Sponsor study identifier
observational
3
1 country
4
Study Start
August 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2020
Actual (reported)Study Completion
January 2020
Actual (reported)The purpose of this study is to see if a positron emission tomography/computed tomography (PET/CT) scan and a magnetic resonance imaging (MRI) of the chest can assess changes in the thymus size and function. The researchers would like to monitor the thymus with a PET/CT scan and a MRI before and after the participants transplantation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2016
Date type not reportedThis date has not been verified as actual or estimated.
September 19, 2016
Actual (reported)September 21, 2016
Actual (reported)January 2020
Actual (reported)January 2020
Actual (reported)change in thymic size
A clinically meaningful change is defined as increase in thymic size (\> 0.2cm increase in uni-dimensional diameter), functional volume (\>10%) or uptake (≥25%). We will report proportion of patients with each component of clinically meaningful change, as well as the proportion with at least one component, along 95% exact confidence intervals.
1 year
Eligible patients will be enrolled onto the study, and will undergo 3 limited field of view (FOV) FDG-PET/CT scans and MRI of the chest: at baseline (within 4 weeks prior to transplantation), and approximately 3 months (+/-2 weeks) and 6 months (+/-2 weeks) after transplant. PET/CT and MR imaging can be completed on the same day. We will also offer the exams on other days if this is easier for the patient. The PET/CT and MR should be performed within 2 weeks of each other.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
MSK BMT clinic
Memorial Sloan Kettering Cancer Center
Basking Ridge, New Jersey, 07920, United States
Memorial Sloan-Kettering Cancer Center at Commack
Commack, New York, United States
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Heiko Schoder, MD
Memorial Sloan Kettering Cancer Center
3 participants (actual enrollment reported by the registry).
First Submitted
September 19, 2016
First Posted
September 21, 2016
Study Start
August 2016
Date type not reportedThis date has not been verified as actual or estimated.
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
Contact the study team to confirm eligibility.
Primary Completion
January 2020
Actual (reported)Study Completion
January 2020
Actual (reported)Last Updated
January 27, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: